📰 Robert Barrow News
Page 9 - Robert Barrow News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Robert Barrow. Real-time updates on events, politics, business and more.
June 5, 2023
ISS Believes Company’s Director Nominees Represent an “Unusually Strong” Group of Current and Former Executives From Relevant Fields and Are Best Suited to Continue Overseeing... | June 5, 2023
May 25, 2023
Independent Third-Party Firm, Led by Former Senior FDA Officials, Calls Phase 2b Trial “Well-designed” and “Essential” Report Further Demonstrates that FCM’s Proposal... | May 25, 2023
May 24, 2023
- Preclinical data in ASD model demonstrate prosocial effects of MM-402 - Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical
May 23, 2023
Low unemployment rates main reason for Kuwaitis KUWAIT CITY, May 23: Economist Steve Hanke of the Johns Hopkins University says Kuwaitis are the happiest Arab people and the second happiest people in the world, after Switzerland on a list of 157 countries as shown by the Misery Index, reports Al-
May 17, 2023
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Rating) has earned an average rating of “Buy” from the nine research firms that are currently covering the company, Marketbeat reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have covered the stock in the last year is […]
May 17, 2023
- Over 50% of patients dosed across 20 active clinical sites - - On Track for Topline Results in late 2023 - Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed")
May 17, 2023
Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.
May 17, 2023
– Over 50% of patients dosed across 20 active clinical sites – – On Track for Topline Results in late 2023 – ... | June 12, 2023
May 15, 2023
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Rating) has been assigned an average rating of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued ratings on the stock in the […]
May 13, 2023
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Rating) – Investment analysts at HC Wainwright decreased their Q2 2023 earnings per share estimates for shares of Mind Medicine (MindMed) in a research note issued to investors on Tuesday, May 9th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn ($0.56) per share for […]